Haha! Gracious man! Now that that's out of the way, let's address your concerns and then talk about why I'm going to be able to sell the vast majority of my shares at $2+.
If you go read the statements you will find a gigantic staircase of warrants with increasingly greater execution prices, which he will proceed to execute if the price rallies higher, gaining him tons of cheap shares to dump on bandwagon idiots for an instant profit.
Let me start off by saying, I have no delusions about the staircase of warrants in front of this stock price. There are a lot of warrants out there to be exercised, and not just by Dart, either.
Brio Capital Master Fund: 25 mil warrants to exercise. Empery Asset Master: 18 mil warrants to exercise. Dart's Eastern Capital: Another 20 mil warrants to exercise. Iroquois Capital: Another 9 mil warrants to exercise. American Capital: 37.5 mil warrants to exercise.
That's over 100,000,000 shares that could potentially come into play! And (I believe) it's only a brief matter of time before these warrants are exercised, too.
However, a couple things to note:
These warrants have been around for quite some time now, and anyone who buys into this stock and has done any research knows about them. TapImmune likely used the Black-Scholes Model and evaluated where their stock price would stand if all of a sudden everyone started to dump their shares onto the open market, and decided that the stock would stand the test of time. Keep in mind that this is a virtually debt-free company who had many options for financing.
This company is a long-term investment for all the institutional investors involved. That was one of the things that TapImmune touched on in their recent conference call: The reason they chose to do business with Eastern Capital Limited is because they felt that Dart would hold long-term. They could be full of shit. But again... they had options to raise the capital they needed for Phase II, and this is the route they chose. It's not a bad path. And I agree. When Dart bought up the debt of struggling countries and sharked them into paying outrageous prices, it wasn't an overnight play. This was something that took years to finalize. He is a son-of-a-bitch. But, he holds long-term.
But, let's say he doesn't hold long-term. Let's say he just dumps his shares at the first opportunity. What... he owns 30 percent of the company once all warrants are exercised? A lot of shares he's picking up at .50 cents? If he started selling when the stock reached 2.00 a share, he's going to dilute the market all the way down for what.... a 4-bagger? Institutional investors are smarter than that. They're not day-traders. They aim to earn many multiplies of their original investment. Dart understands this company's potential, and won't sell until this stock is trading much much higher than it is now.
lol nvm, the patent they list on their website for Her2/neu A) was assigned to the NIH and B) never granted
Their pipeline drug is solid. There were no side-effects. The drug is safe, and it will be very affordable when it goes to market.
http://seekingalpha.com/article/2505615-does-tapimmune-have-what-it-takes-to-succeed
Their website also totes that while Neuvax has a drug in Phase 3, TapImmune's drug candidate has a 5x killing efficacy compared with neuvax. (http://www.tapimmune.com/technology/clinical/) Galena is creating the original slow-ass Iphone. Meanwhile, homies over at TapImmune are already working on the Galaxy S6. Galena will get a couple good years of sales before TapImmune comes along and sucks up all their market share, assuming both drugs make it to market.